Detalhe da pesquisa
1.
Revaccination of patients with systemic lupus erythematosus or rheumatoid arthritis without an initial COVID-19 vaccine response elicits seroconversion in half of the patients.
Clin Exp Rheumatol
; 42(1): 157-165, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37877429
2.
COVID-19 vaccination in patients with rheumatic diseases leads to a high seroconversion rate and reduced self-imposed isolation and shielding behaviour.
Mod Rheumatol
; 33(4): 777-785, 2023 Jul 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35860843
3.
Local and systemic reactogenicity of COVID-19 vaccine BNT162b2 in patients with systemic lupus erythematosus and rheumatoid arthritis.
Rheumatol Int
; 41(11): 1925-1931, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-34476603
4.
Time Since Rituximab Treatment Is Essential for Developing a Humoral Response to COVID-19 mRNA Vaccines in Patients With Rheumatic Diseases.
J Rheumatol
; 49(6): 644-649, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35232803
5.
Reactive arthritis after COVID-19.
BMJ Case Rep
; 14(3)2021 Mar 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33653867